Pharmagreen Biotech Inc. PHBI
Pharmagreen Biotech Inc. (PHBI) earns a Piotroski F-score of 2/9 (weak financial health). It does not currently pay a dividend.
Quality score trend · recomputed for each fiscal year
Each year's score is computed from that year's filing — a rising Piotroski F or Altman Z″ means improving financial health, a fall is worth a look.
How it ranks in Transportation & Utilities · percentile among 348 companies
Percentile vs other Transportation & Utilities companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.
Piotroski F breakdown · 2/9 tests passed
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Sector peers · similar-size Transportation & Utilities companies compare side by side →
| Ticker | Company | Piotroski F | Altman Z″ | P / E | Revenue growth |
|---|---|---|---|---|---|
| PHBI | Pharmagreen Biotech Inc. | 2/9 | — | — | — |
| NPPXF | NIPPON TELEGRAPH & TELEPHONE CORP | 6/9 | 2.95 | — | -1.3% |
| VZ | VERIZON COMMUNICATIONS INC | 4/9 | 1.53 | 11.4 | +2.5% |
| T | AT&T INC. | 6/9 | 0.88 | 7.2 | +2.7% |
| CCZ | COMCAST CORP | 6/9 | 1.79 | 4.9 | +-0% |
| FDX | FEDEX CORP | 5/9 | 2.66 | 17.1 | +7.7% |
| UPS | UNITED PARCEL SERVICE INC | 5/9 | 2.23 | 16.8 | -2.6% |
All Transportation & Utilities companies →
About Pharmagreen Biotech Inc.
Pharmagreen Biotech Inc. operates as a nutraceutical company, engages in the formulating products from blends of therapeutic plants and fungi in North America. The company's primary product is MaxGenomic supplement, a proprietary blend and formulated medicinal mushrooms and medical plants to support the human mind and body. It also provides consulting services for plant genetic selection, tissue culture technologies for starter plantlets production, SOPs for cultivation and live storage of any plant species services. It sells its products through online stores, such as Amazon and Shopify. Pharmagreen Biotech Inc. is headquartered in Coquitlam, Canada.
FAQ
Is PHBI financially healthy?
Pharmagreen Biotech Inc.'s Piotroski F-score is 2/9 (8–9 is excellent, 0–3 weak).
Does PHBI pay a dividend?
No, Pharmagreen Biotech Inc. does not currently pay a dividend.
Is PHBI a good stock to buy?
Stocktoria doesn't give buy or sell advice, but here is the data on Pharmagreen Biotech Inc.: a Piotroski F-score of 2/9. Weigh these quality and valuation signals against your own goals.
Computed from company filings · US · as of 2022-09-30. Facts plus Stocktoria's own computed scores — not investment advice.